SEC 13F Intelligence

Regeneron Pharmaceuticals, Inc. / NTLA

Regeneron Pharmaceuticals, Inc.’s Intellia Therapeutics Inc Position

Does Regeneron Pharmaceuticals, Inc. own Intellia Therapeutics Inc (NTLA)? Yes — 3.70M shares worth $47M (+99.14% of its 13F portfolio) as of Q1 2026.

Position Value
$47M
Q1 2026
Shares
3.70M
% of Portfolio
+99.14%
Quarters Held
6
currently held

Position History NTLA

Reported value by quarter
Q4 ’24: $43MQ4 ’24Q1 ’25: $26MQ1 ’25Q2 ’25: $35MQ2 ’25Q3 ’25: $64MQ3 ’25Q4 ’25: $33MQ4 ’25Q1 ’26: $47MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20263.70M$47M+99.14%
Q4 20253.70M$33M+98.49%
Q3 20253.70M$64M+9.13%
Q2 20253.70M$35M+2.34%
Q1 20253.70M$26M+2.13%
Q4 20243.70M$43M+3.94%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Regeneron Pharmaceuticals, Inc.’s full portfolio or all institutional holders of NTLA.